Cargando…
Establishment of Novel Mouse Model of Dietary NASH Rapidly Progressing into Liver Cirrhosis and Tumors
SIMPLE SUMMARY: Non-alcoholic steatohepatitis (NASH) may progress into liver cirrhosis and hepatocellular carcinoma (HCC). NASH has been recognized as a major cause of HCC, which is the third leading cause of cancer-related deaths worldwide. However, the development of drug therapy for NASH and ensu...
Autores principales: | Zheng, Qianqian, Kawaguchi, Masaya, Mikami, Hayato, Diao, Pan, Zhang, Xuguang, Zhang, Zhe, Nakajima, Takero, Iwadare, Takanobu, Kimura, Takefumi, Nakayama, Jun, Tanaka, Naoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378543/ https://www.ncbi.nlm.nih.gov/pubmed/37509405 http://dx.doi.org/10.3390/cancers15143744 |
Ejemplares similares
-
Clinically Relevant Dose of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα), Lowers Serum Triglyceride Levels by Targeting Hepatic PPARα in Mice
por: Zhang, Zhe, et al.
Publicado: (2022) -
Acidic Activated Charcoal Prevents Obesity and Insulin Resistance in High-Fat Diet-Fed Mice
por: Zhang, Xuguang, et al.
Publicado: (2022) -
Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis
por: Hayashi, Momoko, et al.
Publicado: (2023) -
NASH‐related cirrhosis: An occult liver disease burden
por: Arrese, Marco, et al.
Publicado: (2017) -
Fatty Acid Accumulation and Resulting PPARα Activation in Fibroblasts due to Trifunctional Protein Deficiency
por: Wakabayashi, Masato, et al.
Publicado: (2012)